Normal urinary growth hormone measurement in short-stature early pubertal boys may help to exclude growth hormone

Insights

Urinary growth hormone (U-GH) measurement can predict growth rates in short-stature boys. Higher U-GH levels in these boys may indicate normal growth, potentially delaying provocative testing.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Physiology

Background:

  • Constitutional short stature (CSS) in boys presents diagnostic challenges.
  • Assessing growth hormone (GH) secretion is crucial for managing short stature.
  • Pharmacological tests for GH deficiency can be invasive and sometimes yield ambiguous results.

Purpose of the Study:

  • To evaluate the utility of urinary growth hormone (U-GH) as a predictor of growth rate in young boys.
  • To compare U-GH levels in boys with CSS to those in normal and GH-deficient children.

Main Methods:

  • U-GH concentrations were measured in five early pubertal boys with CSS.
  • U-GH levels were compared with those from normal prepubertal/pubertal children and GH-deficient children.
  • U-GH results were correlated with subsequent growth rates and plasma GH responses to provocative tests.

Main Results:

  • In boys with CSS, U-GH levels ranged from 3.7 to 9.7 ng/night, indicating normal growth potential despite blunted plasma GH responses.
  • Normal prepubertal and pubertal children had U-GH levels of 2.2 +/- 0.2 and 4.1 +/- 0.5 ng/night, respectively.
  • GH-deficient children showed lower U-GH levels (1.1 +/- 0.2 ng/night) compared to CSS and normal groups.

Conclusions:

  • U-GH measurement appears to be a useful indicator of subsequent growth rate in early pubertal boys with CSS.
  • U-GH may normalize earlier than provocative GH testing, especially with rising sex steroids.
  • U-GH values above 2.6 ng/night in CSS boys might warrant delaying provocative tests and observing growth.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.